The cost of the UK-US pharmaceutical deal cannot be predicted reliably because future medicines spending depends on ‘many factors'.
Health bosses have confirmed the five new prescribing pathways that will be added to the Pharmacy First scheme this autumn.
New AI models should have staged authorisations and continuous monitoring by the medical devices regulator, an commission has ...
A collaboration between the University of Nottingham and Boots seeks to explore how technology-enabled services can improve patient outcomes.
A pharmacy charity has brought its services and information together into four key areas to create a ‘clearer journey’ for ...
Two UK pharmacists have taken up senior leadership positions on an international pharmacy board representing 5.5 million professionals.
The roll-out of GP walk-in centres across Scotland risk widening health inequalities and sowing confusion over where patients ...
The shortlist for the General Practice Awards 2026 is set to be revealed in the next couple of weeks, following another ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new treatment for adults with chronic spontaneous urticaria (CSU) – a long-term condition that causes recurrent hives, ...
Two-in-five children living with obesity achieved a body mass index (BMI) below the obesity threshold when taking weight-loss injections, a new study has found. Early results from the STEP Young phase ...
How would it affect your career if you had a long-term health problem? Pharmacists with a disability, or those who develop one, need the support of their employer, says Liz Larkin of the Pharmacists’ ...
An adrenaline nasal spray to treat anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). EURneffy, a single-dose container that delivers 2mg of epinephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results